Sino Biopharmaceutical

AstraZeneca, GSK strike deals with Sino Biopharma amid U.S. scrutiny

AstraZeneca and GSK announced separate partnerships with China's Sino Biopharmaceutical on Wednesday, marking a flurry of cross-border pharmaceutical dealmaking even as U.S. lawmakers push to bring such transactions under national security review.